Epigallocatechin-3-gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase-2

Molecular Medicine Reports

Volumn 9, Issue 3, 2014, Pages 1085-1089

  Wang, Feng ^a   Chang, Zhiwei ^a   Fan, Qingxia ^a   Wang, Liuxing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Epigallocatechin 3 gallate; Matrix metalloproteinase 2 9; Mitogen activated protein kinases; Ovarian cancer; Proliferation and migration

Indexed keywords

ANTICARCINOGENIC AGENTS; CARCINOMA; CATECHIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; FEMALE; HUMANS; IMIDAZOLES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PYRIDINES;

EID: 84893844214     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.1909     Document Type: Article

References (29)

1. Katiyar SK and Elmets CA: Green tea polyphenolic antioxidants and skin photoprotection (Review). Int J Oncol 18: 1307-1313, 2001.
2. Singh BN, Shankar S and Srivastava RK: Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82: 1807-1821, 2011.
3. Mukhtar H and Ahmad N: Green tea in chemoprevention of cancer. Toxicol Sci 52 (2 Suppl): S111-S117, 1999.
4. Hsu YC and Liou YM: The anti-cancer effects of (-)-epigallocatechin-3- gallate on the signaling pathways associated with membrane receptors in MCF-7 cells. J Cell Physiol 226: 2721-2730, 2011.
5. Shankar S, Ganapathy S, Hingorani SR and Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci 13: 440-452, 2008.
6. Sukhthankar M, Alberti S and Baek SJ: Epigallocatechin-3-gallate (EGCG) post-transcriptionally and post-translationally suppresses the cell proliferative protein TROP2 in human colorectal cancer cells. Anticancer Res 30: 2497-2503, 2010.
7. Onoda C, Kuribayashi K, Nirasawa S, Tsuji N, Tanaka M, Kobayashi D and Watanabe N: (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression. Int J Oncol 38: 1403-1408, 2011.
8. Cho KR and Shih IeM: Ovarian cancer. Annu Rev Pathol 4: 287-313, 2009.
9. Urban N and Drescher C: Potential and limitations in early diagnosis of ovarian cancer. Adv Exp Med Biol 622: 3-14, 2008.
10. Mizutani K, Ito H, Iwamoto I, et al: Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage- independent growth. Oncogene 26: 7122-7131, 2007.
11. Ray RM, Vaidya RJ and Johnson LR: MEK/ERK regulates adherens junctions and migration through Rac1. Cell Motil Cytoskeleton 64: 143-156, 2007.
12. Kim EK and Choi EJ: Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802: 396-405, 2010.
13. Kang YH, Yang IJ and Shin HM: Herbal formula HMC05 prevents human aortic smooth muscle cell migration and proliferation by inhibiting the ERK1/2 MAPK signaling cascade. J Nat Med 66: 177-184, 2012.
14. Gayer CP, Craig DH, Flanigan TL, Reed TD, Cress DE and Basson MD: ERK regulates strain-induced migration and proliferation from different subcellular locations. J Cell Biochem 109: 711-725, 2010.
15. Tangkijvanich P, Santiskulvong C, Melton AC, Rozengurt E and Yee HF Jr: p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts. J Cell Physiol 191: 351-361, 2002.
16. Li T, Feng Z, Jia S, Wang W, Du Z, Chen N and Chen Z: Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway. Breast Cancer Res Treat 131: 891-898, 2012.
17. Xue A, Xue M, Jackson C and Smith RC: Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. Int J Biochem Cell Biol 41: 1731-1738, 2009.
18. Choi BD, Jeong SJ, Wang G, Park JJ, Lim DS, Kim BH, Cho YI, Kim CS and Jeong MJ: Secretory leukocyte protease inhibitor is associated with MMP-2 and MMP-9 to promote migration and invasion in SNU638 gastric cancer cells. Int J Mol Med 28: 527-534, 2011.
19. Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11: 1696-1701, 2006.
20. Hilger RA, Scheulen ME and Strumberg D: The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 25: 511-518, 2002.
21. Geest CR and Coffer PJ: MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 86: 237-250, 2009.
22. Brooks SA, Lomax-Browne HJ, Carter TM, et al: Molecular interactions in cancer cell metastasis. Acta Histochem 112: 3-25, 2010.
23. Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20: 161-168, 2010.
24. Roy R, Yang J and Moses MA: Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297, 2009.
25. Hwang ES and Park KK: Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem 74: 961-967, 2010.
26. Sun LC, Luo J, Mackey LV, Fuselier JA and Coy DH: A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9. Cancer Lett 246: 157-166, 2007.
27. Schmalfeldt B, Prechtel D, Härting K, Späthe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W and Lengyel E: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 7: 2396-2404, 2001.
28. Deng YT and Lin JK: EGCG inhibits the invasion of highly invasive CL1-5 lung cancer cells through suppressing MMP-2 expression via JNK signaling and induces G2/M arrest. J Agric Food Chem 59: 13318-13327, 2011.
29. Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M and Chatterjee A: Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 84: 194-204, 2009.